NO831654L - Analogifremgangsmaate for fremstilling av farmakologisk aktive spiro-imidazolidin-indolin-derivater - Google Patents

Analogifremgangsmaate for fremstilling av farmakologisk aktive spiro-imidazolidin-indolin-derivater

Info

Publication number
NO831654L
NO831654L NO831654A NO831654A NO831654L NO 831654 L NO831654 L NO 831654L NO 831654 A NO831654 A NO 831654A NO 831654 A NO831654 A NO 831654A NO 831654 L NO831654 L NO 831654L
Authority
NO
Norway
Prior art keywords
formula
bromo
trifluoromethyl
imidazolidine
indoline
Prior art date
Application number
NO831654A
Other languages
English (en)
Norwegian (no)
Inventor
David Robert Brittain
David Brown
Robin Wood
Original Assignee
Ici Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc filed Critical Ici Plc
Publication of NO831654L publication Critical patent/NO831654L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO831654A 1982-05-11 1983-05-10 Analogifremgangsmaate for fremstilling av farmakologisk aktive spiro-imidazolidin-indolin-derivater NO831654L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8213651 1982-05-11
GB8231129 1982-11-01

Publications (1)

Publication Number Publication Date
NO831654L true NO831654L (no) 1983-11-14

Family

ID=26282800

Family Applications (1)

Application Number Title Priority Date Filing Date
NO831654A NO831654L (no) 1982-05-11 1983-05-10 Analogifremgangsmaate for fremstilling av farmakologisk aktive spiro-imidazolidin-indolin-derivater

Country Status (12)

Country Link
US (1) US4539329A (index.php)
EP (1) EP0101149A1 (index.php)
AU (1) AU566869B2 (index.php)
CA (1) CA1201124A (index.php)
DK (1) DK190683A (index.php)
ES (1) ES522295A0 (index.php)
FI (1) FI831439A7 (index.php)
GR (1) GR78145B (index.php)
IL (1) IL68572A (index.php)
NO (1) NO831654L (index.php)
NZ (1) NZ204189A (index.php)
PT (1) PT76652B (index.php)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
US20030014951A1 (en) * 2001-07-20 2003-01-23 Ingersoll-Rand Company Horizontal separator tank for oil-flooded air compressor
WO2007091948A2 (en) * 2006-02-07 2007-08-16 Astrazeneca Ab Novel spiro [imidazolidine-4, 3´-indole] 2, 2´,5´(1h) triones for treatment of conditions associated with vanilloid receptor 1

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3767653A (en) * 1971-06-28 1973-10-23 Squibb & Sons Inc Thiazines
US4053613A (en) * 1975-09-17 1977-10-11 E. R. Squibb & Sons, Inc. 1,3,thiazolinyl and 1,3 thiazinyl substituted indolinones
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
IE53102B1 (en) * 1981-05-12 1988-06-22 Ici Plc Pharmaceutical spiro-succinimide derivatives
GB2098212B (en) * 1981-05-12 1984-11-14 Ici Plc Process for preparing 1'-substituted-spiro(imidazolidine)-4,3'-indoline-2,2',5-triones
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives
GB8312379D0 (en) * 1983-05-05 1983-06-08 Ici Plc Heterocyclic compounds

Also Published As

Publication number Publication date
ES8407050A1 (es) 1984-08-16
IL68572A (en) 1986-01-31
EP0101149A1 (en) 1984-02-22
US4539329A (en) 1985-09-03
AU1383883A (en) 1983-11-17
ES522295A0 (es) 1984-08-16
FI831439L (fi) 1983-11-12
DK190683D0 (da) 1983-04-28
AU566869B2 (en) 1987-11-05
FI831439A7 (fi) 1983-11-12
PT76652B (en) 1986-02-04
CA1201124A (en) 1986-02-25
PT76652A (en) 1983-06-01
NZ204189A (en) 1985-08-30
DK190683A (da) 1983-11-12
GR78145B (index.php) 1984-09-26
FI831439A0 (fi) 1983-04-27
IL68572A0 (en) 1983-09-30

Similar Documents

Publication Publication Date Title
US4855298A (en) 6-Halo-1,2,3,4-tetrahydroquinazoline-4-spiro-4-imidazolidine-2,2'5'-triones useful for the treatment and prophylaxis of diabetic complications
EP0065392B1 (en) Pharmaceutical compositions containing spiro succinimide derivatives
NO154346B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalazin-4-yl-eddiksyrederivater.
KR850001228B1 (ko) 치환 인돌린-2-온 유도체의 제조방법
EP0066378B1 (en) Pharmaceutical spiro-hydantoin derivatives
NO831654L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive spiro-imidazolidin-indolin-derivater
EP0125090B1 (en) Indoline derivatives
EP0065393B1 (en) Pyrrole derivatives
US4544662A (en) 1'-Substituted-spiro[oxazolidine-5-3'-indoline]-2,2', 4-trione derivatives
GB2098212A (en) Process for preparing 1'-substituted- spiro imidazolidine-4,3'- indoline-2,2',5-triones
EP0168181B1 (en) Cyclic amides
GB2119797A (en) Fluoroalkyl derivatives
US4649222A (en) 2-(substituted amino)-2-[2-hydroxy-2-alkyl (or phenyl)ethyl]tricyclo[3.3.1.13,7 ]decane hydrohalides
NO774035L (no) Nye 2-sulfonyl (resp. -sulfinyl)-2`-aminoacetofenoner og fremgangsmaate til deres fremstilling
US4423232A (en) Tricyclic isoindole derivatives
US3274188A (en) 5-aminobenzocarbazoles
US4323572A (en) Antihypertensive tricyclic isoindole derivatives
JPS58206592A (ja) トリフルオロメチルスピロ〔イミダゾリジン−４，３′−インドリン〕−２，２′，５−トリオン、その製法および該化合物を含有する糖尿病またはガラクト−ス血症の合併症の治療または予防に使用するための製薬組成